Glem Lin Mxr (25Mg/5Mg/1000Mg) 14 Tablets
Glimepiride/linagliptin/metformin XR triple therapy for type 2 diabetes.
Glem Lin MXR combines Glimepiride, Linagliptin, and Metformin extended-release for type 2 diabetes when triple therapy is indicated. It improves glycaemic control through insulin release, incretin effect, and reduced hepatic glucose.
Purpose
Type 2 diabetes with diet and exercise when triple therapy is indicated.
Ingredients
Glimepiride 2.5mg (or as per strength), Linagliptin 5mg, Metformin Hydrochloride 1000mg (extended-release)
Warnings
Hypoglycaemia risk. Not for type 1 diabetes or DKA. Lactic acidosis risk with metformin. Avoid if eGFR below 45. Prescription only.
Side Effects
Hypoglycaemia, lactic acidosis (metformin), GI effects, nasopharyngitis.
Storage Instructions
Store below 30°C. Keep in original pack. Protect from moisture.
| Brand | Nabiqasim |
| Status | Active |
Related Products
